Related Experiment Video
Updated: Nov 24, 2025
Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
Published on: April 14, 2023
Key Metabolic Functions of β-Arrestins: Studies with Novel Mouse Models
Sai P Pydi1, Luiz F Barella1, Jaroslawna Meister1
1Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Abstract:
β-Arrestin-1 and -2 are intracellular proteins that are able to inhibit signaling via G protein-coupled receptors (GPCRs). However, both proteins can also modulate cellular functions in a G protein-independent fashion. During the past few years, studies with mutant mice selectivity lacking β-arrestin-1 and/or -2 in metabolically important cell types have led to novel insights into the mechanisms through which β-arrestins regulate key metabolic processes in vivo, including whole-body glucose and energy homeostasis. The novel information gained from these studies should inform the development of novel drugs, including β-arrestin- or G protein-biased GPCR ligands, that could prove useful for the therapy of several important pathophysiological conditions, including type 2 diabetes and obesity.
Insights
Beta-arrestins (β-arrestins) are key regulators of G protein-coupled receptor (GPCR) signaling and cellular functions. Studies using knockout mice reveal their critical role in metabolic homeostasis, paving the way for new diabetes and obesity therapies.
Area of Science:
- Molecular and Cellular Biology
- Endocrinology and Metabolism
- Pharmacology
Background:
- Beta-arrestins (β-arrestins) are intracellular proteins known to inhibit G protein-coupled receptor (GPCR) signaling.
- These proteins also exhibit G protein-independent functions, influencing various cellular processes.
- Understanding β-arrestin roles is crucial for metabolic regulation.
Purpose of the Study:
- To investigate the in vivo mechanisms by which β-arrestins regulate whole-body glucose and energy homeostasis.
- To explore the G protein-dependent and -independent functions of β-arrestin-1 and -2 in metabolic processes.
- To identify therapeutic targets for metabolic disorders based on β-arrestin signaling.
Main Methods:
- Utilized mutant mice selectively lacking β-arrestin-1 and/or -2 in metabolically relevant cell types.
- Analyzed effects on whole-body glucose homeostasis and energy balance.
- Investigated G protein-dependent and -independent signaling pathways.
Main Results:
- Novel insights into β-arrestin regulation of key metabolic processes in vivo were obtained.
- Demonstrated the significant role of β-arrestins in maintaining glucose and energy homeostasis.
- Highlighted the distinct contributions of β-arrestin-1 and -2 in metabolic control.
Conclusions:
- β-arrestins are critical regulators of whole-body metabolic homeostasis.
- Findings support the development of novel therapeutics targeting β-arrestin or biased GPCR ligands.
- Potential applications include therapies for type 2 diabetes and obesity.
